Salehi M, Barkhori Mehni M, Akbarian M, Fattah Ghazi S, Khajavi Rad N, Moradi Moghaddam O, Jamali Moghaddam S, Hosseinzadeh Emam M, Abtahi SH, Moradi M, Ghiasvand F. The outcome of using intravenous immunoglobulin (IVIG) in critically ill COVID-19 patients': a retrospective, multi-centric cohort study. Eur J Med Res 2022;27:18. [PMID: 35115056 DOI: 10.1186/s40001-022-00637-8][Cited by in Crossref: 1][Cited by in F6Publishing: 1][Article Influence: 1.0][Reference Citation Analysis]
Number
Citing Articles
1
Liu X, Zhang Y, Lu L, Li X, Wu Y, Yang Y, Li T, Cao W. Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis. Front Immunol 2023;14:1116738. [PMID: 36756131 DOI: 10.3389/fimmu.2023.1116738][Reference Citation Analysis]
2
Bao WJ, Fu SK, Zhang H, Zhao JL, Jin HM, Yang XH. Clinical characteristics and short-term mortality of 102 hospitalized hemodialysis patients infected with SARS-CoV-2 omicron BA.2.2.1 variant in Shanghai, China. New Microbes and New Infections 2022. [DOI: 10.1016/j.nmni.2022.101058][Reference Citation Analysis]
3
Grebennikov D, Karsonova A, Loguinova M, Casella V, Meyerhans A, Bocharov G. Predicting the Kinetic Coordination of Immune Response Dynamics in SARS-CoV-2 Infection: Implications for Disease Pathogenesis. Mathematics 2022;10:3154. [DOI: 10.3390/math10173154][Reference Citation Analysis]
